BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34175038)

  • 1. COVID-19 pandemic causes cervical cancer screening crisis.
    Gourd E
    Lancet Oncol; 2021 Aug; 22(8):1060. PubMed ID: 34175038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Economic aspects of using selected biomarkers in cervical cancer screening].
    Rokita W; Kedzia W; Gaj A; Kulig B
    Ginekol Pol; 2010 Oct; 81(10):774-7. PubMed ID: 21117306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact on women's health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium.
    Tjalma WAA; Kim E; Vandeweyer K
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():171-181. PubMed ID: 28081908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Cancer Screening Among Medicaid Patients During Natural Disasters and the COVID-19 Pandemic in Puerto Rico, 2016 to 2020.
    Ortiz AP; Gierbolini-Bermúdez A; Ramos-Cartagena JM; Colón-López V; Sonawane K; Deshmukh AA; Ortiz-Ortiz KJ
    JAMA Netw Open; 2021 Oct; 4(10):e2128806. PubMed ID: 34652451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening.
    Poljak M; Cuschieri K; Waheed DE; Baay M; Vorsters A
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):21-26. PubMed ID: 33765753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a summary January 2021.
    Jach R; Mazurec M; Trzeszcz M; Zimmer M; Kedzia W; Wolski H
    Ginekol Pol; 2021; 92(2):165-173. PubMed ID: 33751524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cervical cancer in low-resource settings in 2011.
    Patrizzi B
    Arch Pathol Lab Med; 2014 Feb; 138(2):156. PubMed ID: 24476514
    [No Abstract]   [Full Text] [Related]  

  • 8. The COVID-19 pandemic and its implications for cervical cancer treatment and prevention in Zimbabwe: perspectives and recommendations.
    Murewanhema G
    Pan Afr Med J; 2021; 39():149. PubMed ID: 34527165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical screening coverage in England before and during COVID-19.
    Armitage R
    Public Health; 2021 Sep; 198():e11. PubMed ID: 34099318
    [No Abstract]   [Full Text] [Related]  

  • 10. In reply.
    Tambouret R; Roberts DJ
    Arch Pathol Lab Med; 2014 Feb; 138(2):156. PubMed ID: 24476513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cervical cancer in low-resource settings in 2011.
    Tambouret R
    Arch Pathol Lab Med; 2013 Jun; 137(6):782-90. PubMed ID: 23721273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 on cervical cancer screening.
    Mungmunpuntipamtip R; Wiwanitkit V
    Eur J Cancer Prev; 2022 Jul; 31(4):400. PubMed ID: 34456261
    [No Abstract]   [Full Text] [Related]  

  • 14. Women's health: 2011 updates.
    Weihs D; Wheeler JG
    J Ark Med Soc; 2011 Jul; 108(1):12-3. PubMed ID: 21823558
    [No Abstract]   [Full Text] [Related]  

  • 15. Introducing HPV triage into the English cervical cancer screening program: consequences for participation.
    Philips Z; Avis M; Whynes DK
    Women Health; 2006; 43(2):17-34. PubMed ID: 17000609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health of women and children is central to covid-19 recovery.
    Modi N; Hanson M
    BMJ; 2021 Apr; 373():n899. PubMed ID: 33853852
    [No Abstract]   [Full Text] [Related]  

  • 17. 'Lest we forget' as we move forward with cervical screening.
    Saville M; McNally O
    Aust N Z J Obstet Gynaecol; 2018 Jun; 58(3):265-266. PubMed ID: 29864221
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced cervical cancer screening in Zimbabwe as an indirect impact of the COVID-19 pandemic: implications for prevention.
    Murewanhema G
    Pan Afr Med J; 2021; 38():131. PubMed ID: 33912301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening: How our approach may change.
    Hofmeister S
    J Fam Pract; 2016 Aug; 65(8):551-3. PubMed ID: 27660838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of the randomized control screening trials on oral, cervix and breast cancer from India and way forward in COVID-19 pandemic situation.
    Budukh AM; Dikshit R; Chaturvedi P
    Int J Cancer; 2021 Oct; 149(8):1619-1620. PubMed ID: 34152021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.